Literature DB >> 219129

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.

M Glaser.   

Abstract

When cyclophosphamide was administered to mice before immunization with syngeneic SV40 transformed cells, the specific immune response elicited, as was measured by in vitro 51Cr release assay was stronger and lasted longer when compared to the response generated in noncyclophosphamide-treated mice. The augmentation effect of the drug was dependent on cyclophosphamide concentration being optimal at 100 mg/kg and on the time of drug administration in relation to antigen immunization being optimal at 2 d before antigen administration. Transfer of T cells from normal syngeneic mice to drug-treated animals abolished the cyclophosphamide-induced augmentation of immune response. These results implied that cyclophosphamide sensitive T cells suppressed the in vivo generation of specific effector T cells against SV40-induced tumor-associated antigens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219129      PMCID: PMC2184834          DOI: 10.1084/jem.149.3.774

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.

Authors:  M Glaser
Journal:  J Natl Cancer Inst       Date:  1978-11       Impact factor: 13.506

2.  Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.

Authors:  M Harada; G Pearson; H Pettigrew; L Redmon; T Orr
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  Cell interactions in adoptive immune rejection of a syngeneic tumor.

Authors:  S B Howell; J H Dean; E C Esber; L W Llaw
Journal:  Int J Cancer       Date:  1974-11-15       Impact factor: 7.396

4.  Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.

Authors:  M S Drapkin; E Appella; L W Law
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

Review 5.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

6.  Cyclophosphamide delays 3-methylcholanthrene sarcoma induction in mice.

Authors:  I Hellström; K E Hellström
Journal:  Nature       Date:  1978-09-14       Impact factor: 49.962

7.  Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.

Authors:  J R Berenson; A B Einstein; A Fefer
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

8.  Antigen-induced cyclophosphamide-resistant suppressor T cells inhibit the in vitro generation of cytotoxic cells from one-way mixed leukocyte reactions.

Authors:  B Bonavida
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

9.  Cellular immunity in mice with simian virus 40-induced mKSA tumors: comparison of three assays of tumor immunity.

Authors:  S B Howell; E C Esber; L W Law
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

10.  Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Authors:  M Röllinghoff; A Starzinski-Powitz; K Pfizenmaier; H Wagner
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  26 in total

1.  Protective and immunostimulating activity of a low dose of cyclophosphamide in the experimental infection of mice with foot-and-mouth disease virus.

Authors:  E L Portiansky; W M DiGirolamo; R P Laguens
Journal:  Experientia       Date:  1989-01-15

2.  Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.

Authors:  K Ryoyama; C Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Inverse relationship between anti-SV40 TASA and anti-H-2 cytotoxic responses.

Authors:  C De Giovanni; S Grilli; P L Lollini; G Nicoletti; G Prodi; P Nanni
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 4.  Stimulation of anti-tumor immunity by photodynamic therapy.

Authors:  Pawel Mroz; Javad T Hashmi; Ying-Ying Huang; Norbert Lange; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2011-01       Impact factor: 4.473

5.  Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species-specific viral oncogenicity.

Authors:  J L Cook; J B Hibbs; A M Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

6.  Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers.

Authors:  M M Bartik; B A Baumgartel-Scofield; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.

Authors:  L M Weiskirch; E Barker; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.

Authors:  M M Bartik; M C Ahn; B A Baumgartel; R L Hendricks; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.

Authors:  M J Lawman; B T Rouse; R J Courtney; R D Walker
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

10.  The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.

Authors:  E J Hancock; D G Kilburn
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.